Cargando…
Mistletoe-Based Drugs Work in Synergy with Radio-Chemotherapy in the Treatment of Glioma In Vitro and In Vivo in Glioblastoma Bearing Mice
BACKGROUND: Extracts from Viscum album L. (VE) are used in the complementary cancer therapy in Europe for decades. VE contain several compounds like the mistletoe lectins (MLs) 1-3 and viscotoxins and also several minor ingredients. Since mistletoe lectin 1 (ML-1) has been described as the main comp...
Autores principales: | Schötterl, Sonja, Miemietz, Jennifer T., Ilina, Elena I., Wirsik, Naita M., Ehrlich, Ingrid, Gall, Andrea, Huber, Stephan M., Lentzen, Hans, Mittelbronn, Michel, Naumann, Ulrike |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636536/ https://www.ncbi.nlm.nih.gov/pubmed/31354846 http://dx.doi.org/10.1155/2019/1376140 |
Ejemplares similares
-
Adjuvant Therapy Using Mistletoe Containing Drugs Boosts the T-Cell-Mediated Killing of Glioma Cells and Prolongs the Survival of Glioma Bearing Mice
por: Schötterl, Sonja, et al.
Publicado: (2018) -
Fermented Mistletoe Extract as a Multimodal Antitumoral Agent in Gliomas
por: Podlech, Oliver, et al.
Publicado: (2012) -
Pericytes/vessel-associated mural cells (VAMCs) are the major source of key epithelial-mesenchymal transition (EMT) factors SLUG and TWIST in human glioma
por: Mäder, Lisa, et al.
Publicado: (2018) -
Irradiation enhances the therapeutic effect of the oncolytic adenovirus XVir-N-31 in brain tumor initiating cells
por: Czolk, Rebecca, et al.
Publicado: (2019) -
Mistletoe as an Oxytoxic
Publicado: (1878)